475 related articles for article (PubMed ID: 19050309)
21. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
Macanas-Pirard P; Quezada T; Navarrete L; Broekhuizen R; Leisewitz A; Nervi B; Ramírez PA
PLoS One; 2017; 12(1):e0168888. PubMed ID: 28045930
[TBL] [Abstract][Full Text] [Related]
22. Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.
Welschinger R; Liedtke F; Basnett J; Dela Pena A; Juarez JG; Bradstock KF; Bendall LJ
Exp Hematol; 2013 Mar; 41(3):293-302.e1. PubMed ID: 23178377
[TBL] [Abstract][Full Text] [Related]
23. CXCR4 Antagonist AMD3100 Promotes Mesenchymal Stem Cell Mobilization in Rats Preconditioned with the Hypoxia-Mimicking Agent Cobalt Chloride.
Liu L; Yu Q; Fu S; Wang B; Hu K; Wang L; Hu Y; Xu Y; Yu X; Huang H
Stem Cells Dev; 2018 Apr; 27(7):466-478. PubMed ID: 29433375
[TBL] [Abstract][Full Text] [Related]
24. CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.
Zhang Y; Patel S; Abdelouahab H; Wittner M; Willekens C; Shen S; Betems A; Joulin V; Opolon P; Bawa O; Pasquier F; Ito M; Fujii N; Gonin P; Solary E; Vainchenker W; Coppo P; De Botton S; Louache F
Cell Death Dis; 2012 Oct; 3(10):e396. PubMed ID: 23034331
[TBL] [Abstract][Full Text] [Related]
25. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
De Clercq E
Pharmacol Ther; 2010 Dec; 128(3):509-18. PubMed ID: 20826182
[TBL] [Abstract][Full Text] [Related]
26. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
[TBL] [Abstract][Full Text] [Related]
27. CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism.
Jujo K; Ii M; Sekiguchi H; Klyachko E; Misener S; Tanaka T; Tongers J; Roncalli J; Renault MA; Thorne T; Ito A; Clarke T; Kamide C; Tsurumi Y; Hagiwara N; Qin G; Asahi M; Losordo DW
Circulation; 2013 Jan; 127(1):63-73. PubMed ID: 23204107
[TBL] [Abstract][Full Text] [Related]
28. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
[TBL] [Abstract][Full Text] [Related]
29. Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists.
Mandawat A; Fiskus W; Buckley KM; Robbins K; Rao R; Balusu R; Navenot JM; Wang ZX; Ustun C; Chong DG; Atadja P; Fujii N; Peiper SC; Bhalla K
Blood; 2010 Dec; 116(24):5306-15. PubMed ID: 20810927
[TBL] [Abstract][Full Text] [Related]
30. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.
Lévesque JP; Hendy J; Takamatsu Y; Simmons PJ; Bendall LJ
J Clin Invest; 2003 Jan; 111(2):187-96. PubMed ID: 12531874
[TBL] [Abstract][Full Text] [Related]
31. In and out of the niche: perspectives in mobilization of hematopoietic stem cells.
Mohty M; Ho AD
Exp Hematol; 2011 Jul; 39(7):723-9. PubMed ID: 21624427
[TBL] [Abstract][Full Text] [Related]
32. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
Uy GL; Rettig MP; Cashen AF
Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
[TBL] [Abstract][Full Text] [Related]
33. Concurrent blockade of alpha4-integrin and CXCR4 in hematopoietic stem/progenitor cell mobilization.
Bonig H; Watts KL; Chang KH; Kiem HP; Papayannopoulou T
Stem Cells; 2009 Apr; 27(4):836-7. PubMed ID: 19350684
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.
Song JS; Kang CM; Kang HH; Yoon HK; Kim YK; Kim KH; Moon HS; Park SH
Exp Mol Med; 2010 Jun; 42(6):465-72. PubMed ID: 20498529
[TBL] [Abstract][Full Text] [Related]
35. Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARalpha transgenic mouse model.
Santana BA; Pintão MC; Abreu e Lima RS; Scheucher PS; Santos GA; Garcia AB; Falcão RP; Rego EM
Braz J Med Biol Res; 2006 May; 39(5):615-20. PubMed ID: 16648899
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.
Winkler IG; Pettit AR; Raggatt LJ; Jacobsen RN; Forristal CE; Barbier V; Nowlan B; Cisterne A; Bendall LJ; Sims NA; Lévesque JP
Leukemia; 2012 Jul; 26(7):1594-601. PubMed ID: 22266913
[TBL] [Abstract][Full Text] [Related]
37. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
[TBL] [Abstract][Full Text] [Related]
38. Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100.
Bonig H; Chudziak D; Priestley G; Papayannopoulou T
Exp Hematol; 2009 Mar; 37(3):402-15.e1. PubMed ID: 19157683
[TBL] [Abstract][Full Text] [Related]
39. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM
Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072
[TBL] [Abstract][Full Text] [Related]
40. Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
Peled A; Tavor S
Theranostics; 2013; 3(1):34-9. PubMed ID: 23382784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
